Health Canada Consultation on Priority Review Pathways and Health Care System Needs in Canada
By: Olga Chrzanowska
CSHP members are invited to participate in a Health Canada online consultation regarding the development of accelerated drug review pathways for medication that best address healthcare system needs. The deadline to provide written comments and responses to the questionnaire is April 20, 2018.
Participation in the survey is voluntary. Please know that Health Canada will summarize all responses in aggregate form: all responses will remain anonymous and kept confidential.
Select one of the links below to participate in the consultation:
- English: https://na1se.voxco.com/SE/?st=n1iIrVcw%2fWf1pwY1pCIQ3SXrjjUmJIMtlefmGbF9ciI%3d&lang=en.
- En français: https://na1se.voxco.com/SE/?st=n1iIrVcw%2fWf1pwY1pCIQ3SXrjjUmJIMtlefmGbF9ciI%3d&lang=fr
Should you have technical difficulties with the online consultation, you may send a written submission by email to BGTD_DGO_Enquiries@hc-sc.gc.ca.
Health Canada will continue to meet with provincial and territorial governments and work with Indigenous partners, as well as hold dedicated discussions with stakeholders, to promote an understanding of the proposal and seek further input.
More information about the priority review pathways project can be found here: https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/expanding-priority-review-pathways-for-drugs-meet-health-care-system-needs.html